| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8712032 | Annals of Allergy, Asthma & Immunology | 2017 | 5 Pages |
Abstract
EDN correlated with the disease severity of AD. EDN may predict relapse in severe recalcitrant AD. The EDN serum level could be considered a candidate molecule as a clinical biomarker for evaluating AD disease activity and a predictor of relapse.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Hwan Soo MD, PhD, Ji Hye MD, Yu Mi MD, Yoon Hong MD, PhD, Jong-seo MD, PhD, Hyun Hee MD, PhD, Joon Sung MD, PhD, Jin Tack MD, PhD,